Meghan Trainor Reveals Which Weight-Loss Drug Has Helped Her Become the ‘Healthiest, Strongest Version of Myself for My Kids’
Meghan Trainor revealed which weight-loss drug she has used as she addressed criticism and concern about her appearance in an ...
Drugmakers face market turmoil following FDA shakeup and Trump health overhaul
The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.
Biotech Investors Rush for the Exits After FDA Official Resigns
Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug ...
FDA approves cabozantinib for previously treated advanced neuroendocrine tumors
The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients ...
Pancreatic Cancer Action Network11h
FDA Approves New Treatment for PNETs: What You Need to Know
The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic ...
MyChesCo on MSN17h
FDA Approves GSK’s Blujepa as First New Oral Antibiotic for UTIs in 30 Years
The U.S. Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin), a groundbreaking oral antibiotic for ...
US FDA approves Sanofi's bleeding disorder therapy
The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...
Health on MSN3d
FDA Says Ozempic Is No Longer in Shortage—Does That Mean the End of Cheaper Copycat Versions?
Fact checked by Nick Blackmer Compounded versions of semaglutide, the active ingredient in weight loss drugs like Ozempic and ...
Sanofi’s Easier to Use Hemophilia Drug Approved by US FDA
Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...
US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
Gastroenterology Advisor3d
FDA Approves Gvoke VialDx to Inhibit GI Motility During Diagnostic Procedures
The FDA has approved Gvoke VialDx (glucagon) for IV use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the GI tract.
Fierce Pharma3d
Manufacturing issues trip up Milestone's long-awaited FDA landmark
Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has been a ...